Financial Stability The company has a strong financial position with approximately 91.5 million USD in cash, cash equivalents, and marketable securities as of December 2025, indicating an ability to invest in new services, technology upgrades, or expansion initiatives.

Legal and Patent Focus Given the ongoing patent litigation with Moderna and a notable legal settlement worth up to 2.25 billion USD, there is a potential need for specialized legal, IP management, and compliance services to support companies involved in complex patent disputes in the biopharmaceutical and biotech sectors.

Growth in Biopharma The company's engagement in biotech and pharmaceutical innovations, especially with a pipeline targeting hepatitis B and involvement in high-stakes patent litigations, creates opportunities to offer R&D support, licensing, or specialized consulting services tailored to the biotech industry.

Tech-Driven Solutions Utilizing advanced technologies such as lipid nanoparticle (LNP) delivery systems and digital communication tools, the company is involved in cutting-edge research and legal battles, highlighting potential sales avenues for tech, automation, and intellectual property management solutions.

Market Expansion Opportunities With a focus on compliance, legal disputes, and contractual licensing within the biotech sector, there is potential to provide comprehensive outsourcing, legal administration, and consulting services to facilitate global market entry and IP management for biotech and pharma clients.